Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Ann Oncol. 2022 Oct 5;34(1):111–120. doi: 10.1016/j.annonc.2022.09.163

Figure 2. Elevated TF is prognostic for worse overall survival in the four tumor histologies studied.

Figure 2.

Kaplan–Meier plots of real-world overall survival from therapy start, stratified by tumor fraction at a cut-off of 10% as measured within 60 days prior, in (a) mCRPC, (b) mBC, (c) aNSCLC, and (d) mCRC.

aNSCLC, advanced non-small-cell lung cancer; CI, confidence interval; HR, hazard ratio; mBC, metastatic breast cancer; mCRC, metastatic colorectal cancer; mCRPC, metastatic castration-resistant prostate cancer; NR, not reached; TF, tumor fraction.